SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.

doi:10.3109/07357907.2014.907421

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.

Cancer investigation - 1 Jul 2014

Bui Hoai Thi Thu, Fujimoto Naohiro, Kubo Tatsuhiko, Inatomi Hisato, Matsumoto Tetsuro

Abstract excerpt

A variety of carcinogens are excreted in urine and may be actively transported by organic anion-transporting polypeptides that encoded by SLCOs. In this study, we evaluated whether single nucleotide polymorphisms (SNPs) in SLCO1B1, SLCO2B1, and SLCO1B3 are associated with bladder cancer susceptibility. Our results, for the first time, indicated that polymorphisms of SLCO1B1 rs2306283 might be associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Liver-Specific Organic Anion Transporter 1

Share to Organic Anion Transporters

Share to Organic Anion Transporters, Sodium-Independent

Share to Risk Factors

Share to Solute Carrier Organic Anion Transporter Family Member 1B3

Share to Urinary Bladder Neoplasms

Source

Open in PubMed

Identifiers

PMID: 24762081
DOI: 10.3109/07357907.2014.907421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.PMID 24762081Read ↗

Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.Semantic proximity Read ↗

Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.Semantic proximity Read ↗

Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.Semantic proximity Read ↗

Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.Semantic proximity Read ↗

SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis.Semantic proximity Read ↗

SULT1A1 Arg213His polymorphism is associated with bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

SLCO2B1 genetic polymorphisms in a Korean population: pyrosequencing analyses and comprehensive comparison with other populations.Semantic proximity Read ↗

Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.Semantic proximity Read ↗

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.Semantic proximity Read ↗

Allelic variants in xenobiotic metabolism genes predict susceptibility and worse prognosis of urothelial bladder cancerSemantic proximity Read ↗

Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.